{
  "DOI": "10.1186/1479-7364-6-15",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/1479-7364-6-15",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\n          \u003cjats:p\u003eAlthough mutations in the oncoprotein murine double minute 2 (MDM2) are rare, \u003cjats:italic\u003eMDM2\u003c/jats:italic\u003e gene overexpression has been observed in several human tumors. Given that even modest changes in MDM2 levels might influence the p53 tumor suppressor signaling pathway, we postulated that sequence variation in the promoter region of \u003cjats:italic\u003eMDM2\u003c/jats:italic\u003e could lead to disregulated expression and variation in gene dosage. Two promoters have been reported for \u003cjats:italic\u003eMDM2\u003c/jats:italic\u003e; an internal promoter (P2), which is located near the end of intron 1 and is p53-responsive, and an upstream constitutive promoter (P1), which is p53-independent. Both promoter regions contain DNA variants that could influence the expression levels of \u003cjats:italic\u003eMDM2\u003c/jats:italic\u003e, including the well-studied single nucleotide polymorphism (SNP) SNP309, which is located in the promoter P2; i.e., upstream of exon 2. In this report, we screened the promoter P1 for DNA variants and assessed the functional impact of the corresponding SNPs. Using the dbSNP database and genotyping validation in individuals of European descent, we identified three common SNPs (−1494 G \u0026gt; A; indel 40 bp; and −182 C \u0026gt; G). Three major promoter haplotypes were inferred by using these three promoter SNPs together with rs2279744 (SNP309). Following subcloning into a gene reporter system, we found that two of the haplotypes significantly influenced \u003cjats:italic\u003eMDM2\u003c/jats:italic\u003e promoter activity in a haplotype-specific manner. Site-directed mutagenesis experiments indicated that the 40 bp insertion/deletion variation is causing the observed allelic promoter activity. This study suggests that part of the variability in the \u003cjats:italic\u003eMDM2\u003c/jats:italic\u003e expression levels could be explained by allelic p53-independent P1 promoter activity.\u003c/jats:p\u003e",
  "alternative-id": [
    "11"
  ],
  "article-number": "15",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "22 May 2012"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "31 May 2012"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "1 September 2012"
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Lalonde",
      "given": "Marie-Eve",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Ouimet",
      "given": "Manon",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Larivière",
      "given": "Mathieu",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kritikou",
      "given": "Ekaterini A",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sinnett",
      "given": "Daniel",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2012,
        9,
        1
      ]
    ],
    "date-time": "2012-09-01T20:53:55Z",
    "timestamp": 1346532835000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        9,
        1
      ]
    ],
    "date-time": "2021-09-01T19:51:10Z",
    "timestamp": 1630525870000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        9,
        23
      ]
    ],
    "date-time": "2023-09-23T13:51:42Z",
    "timestamp": 1695477102159
  },
  "is-referenced-by-count": 12,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2012,
        9,
        1
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2012,
          12
        ]
      ]
    }
  },
  "language": "en",
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/1479-7364-6-15.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2012,
        9,
        1
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2012,
        9,
        1
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2012,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1158/0008-5472.CAN-06-2656",
      "author": "W Hu",
      "doi-asserted-by": "publisher",
      "first-page": "2757",
      "journal-title": "Cancer Res",
      "key": "11_CR1",
      "unstructured": "Hu W, Feng Z, Ma L, Wagner J, Rice JJ, Stolovitsky G, Levine AJ: A single nucleotide polymorphism in the MDM2 gene disrupts the oscillation of p53 and MDM2 levels in cells. Cancer Res. 2007, 67: 2757-2765. 10.1158/0008-5472.CAN-06-2656.",
      "volume": "67",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.onc.1208615",
      "author": "SL Harris",
      "doi-asserted-by": "publisher",
      "first-page": "2899",
      "journal-title": "Oncogene",
      "key": "11_CR2",
      "unstructured": "Harris SL, Levine AJ: The p53 pathway: positive and negative feedback loops. Oncogene. 2005, 24: 2899-2908. 10.1038/sj.onc.1208615.",
      "volume": "24",
      "year": "2005"
    },
    {
      "DOI": "10.1002/(SICI)1096-9896(199901)187:1\u003c8::AID-PATH232\u003e3.0.CO;2-Y",
      "author": "WP Bennett",
      "doi-asserted-by": "publisher",
      "first-page": "8",
      "journal-title": "J Pathol",
      "key": "11_CR3",
      "unstructured": "Bennett WP, Hussain SP, Vahakangas KH, Khan MA, Shields PG, Harris CC: Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer. J Pathol. 1999, 187: 8-18. 10.1002/(SICI)1096-9896(199901)187:1\u003c8::AID-PATH232\u003e3.0.CO;2-Y.",
      "volume": "187",
      "year": "1999"
    },
    {
      "DOI": "10.2174/1568009053332627",
      "author": "GL Bond",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "Curr Cancer Drug Targets",
      "key": "11_CR4",
      "unstructured": "Bond GL, Hu W, Levine AJ: MDM2 is a central node in the p53 pathway: 12 years and counting. Curr Cancer Drug Targets. 2005, 5: 3-8. 10.2174/1568009053332627.",
      "volume": "5",
      "year": "2005"
    },
    {
      "DOI": "10.1038/387296a0",
      "author": "Y Haupt",
      "doi-asserted-by": "publisher",
      "first-page": "296",
      "journal-title": "Nature",
      "key": "11_CR5",
      "unstructured": "Haupt Y, Maya R, Kazaz A, Oren M: Mdm2 promotes the rapid degradation of p53. Nature. 1997, 387: 296-299. 10.1038/387296a0.",
      "volume": "387",
      "year": "1997"
    },
    {
      "DOI": "10.1038/387299a0",
      "author": "MH Kubbutat",
      "doi-asserted-by": "publisher",
      "first-page": "299",
      "journal-title": "Nature",
      "key": "11_CR6",
      "unstructured": "Kubbutat MH, Jones SN, Vousden KH: Regulation of p53 stability by Mdm2. Nature. 1997, 387: 299-303. 10.1038/387299a0.",
      "volume": "387",
      "year": "1997"
    },
    {
      "DOI": "10.1016/0092-8674(92)90644-R",
      "author": "J Momand",
      "doi-asserted-by": "publisher",
      "first-page": "1237",
      "journal-title": "Cell",
      "key": "11_CR7",
      "unstructured": "Momand J, Zambetti GP, Olson DC, George D, Levine AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 1992, 69: 1237-1245. 10.1016/0092-8674(92)90644-R.",
      "volume": "69",
      "year": "1992"
    },
    {
      "DOI": "10.1093/nar/26.15.3453",
      "author": "J Momand",
      "doi-asserted-by": "publisher",
      "first-page": "3453",
      "journal-title": "Nucleic Acids Res",
      "key": "11_CR8",
      "unstructured": "Momand J, Jung D, Wilczynski S, Niland J: The MDM2 gene amplification database. Nucleic Acids Res. 1998, 26: 3453-3459. 10.1093/nar/26.15.3453.",
      "volume": "26",
      "year": "1998"
    },
    {
      "DOI": "10.1038/358080a0",
      "author": "JD Oliner",
      "doi-asserted-by": "publisher",
      "first-page": "80",
      "journal-title": "Nature",
      "key": "11_CR9",
      "unstructured": "Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature. 1992, 358: 80-83. 10.1038/358080a0.",
      "volume": "358",
      "year": "1992"
    },
    {
      "DOI": "10.1159/000134368",
      "author": "M Meddeb",
      "doi-asserted-by": "publisher",
      "first-page": "325",
      "journal-title": "Cytogenet Cell Genet",
      "key": "11_CR10",
      "unstructured": "Meddeb M, Valent A, Danglot G, Nguyen VC, Duverger A, Fouquet F, Terrier-Lacombe MJ, Oberlin O, Bernheim A: MDM2 amplification in a primary alveolar rhabdomyosarcoma displaying a t(2;13)(q35;q14). Cytogenet Cell Genet. 1996, 73: 325-330. 10.1159/000134368.",
      "volume": "73",
      "year": "1996"
    },
    {
      "DOI": "10.1182/blood.V82.9.2617.2617",
      "author": "CE Bueso-Ramos",
      "doi-asserted-by": "crossref",
      "first-page": "2617",
      "journal-title": "Blood",
      "key": "11_CR11",
      "unstructured": "Bueso-Ramos CE, Yang Y, deLeon E, McCown P, Stass SA, Albitar M: The human MDM-2 oncogene is overexpressed in leukemias. Blood. 1993, 82: 2617-2623.",
      "volume": "82",
      "year": "1993"
    },
    {
      "DOI": "10.1182/blood.V84.9.3158.3158",
      "author": "T Watanabe",
      "doi-asserted-by": "crossref",
      "first-page": "3158",
      "journal-title": "Blood",
      "key": "11_CR12",
      "unstructured": "Watanabe T, Hotta T, Ichikawa A, Kinoshita T, Nagai H, Uchida T, Murate T, Saito H: The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin. Blood. 1994, 84: 3158-3165.",
      "volume": "84",
      "year": "1994"
    },
    {
      "DOI": "10.1073/pnas.95.26.15608",
      "author": "SN Jones",
      "doi-asserted-by": "publisher",
      "first-page": "15608",
      "journal-title": "Proc Nat Acad Sci U S A",
      "key": "11_CR13",
      "unstructured": "Jones SN, Hancock AR, Vogel H, Donehower LA, Bradley A: Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc Nat Acad Sci U S A. 1998, 95: 15608-15612. 10.1073/pnas.95.26.15608.",
      "volume": "95",
      "year": "1998"
    },
    {
      "DOI": "10.1007/s00109-004-0603-7",
      "author": "JC Knight",
      "doi-asserted-by": "publisher",
      "first-page": "97",
      "journal-title": "J Mol Med (Berlin, Germany)",
      "key": "11_CR14",
      "unstructured": "Knight JC: Regulatory polymorphisms underlying complex disease traits. J Mol Med (Berlin, Germany). 2005, 83: 97-109. 10.1007/s00109-004-0603-7.",
      "volume": "83",
      "year": "2005"
    },
    {
      "DOI": "10.1152/physiolgenomics.00163.2003",
      "author": "T Pastinen",
      "doi-asserted-by": "publisher",
      "first-page": "184",
      "journal-title": "Physiol Genomics",
      "key": "11_CR15",
      "unstructured": "Pastinen T, Sladek R, Gurd S, Sammak A, Gel B, Lepage P, Lavergne K, Villeneuve A, Gaudin T, Brandstrom H, Beck A, Verner A, Kingsley J, Harmsen E, Labuda D, Morgan K, Vohl M-C, Naumova AK, Sinnett D, Hudson TJ: A survey of genetic and epigenetic variation affecting human gene expression. Physiol Genomics. 2004, 16: 184-193.",
      "volume": "16",
      "year": "2004"
    },
    {
      "DOI": "10.1093/hmg/ddl119",
      "author": "JY Park",
      "doi-asserted-by": "publisher",
      "first-page": "1963",
      "journal-title": "Hum Mol Genet",
      "key": "11_CR16",
      "unstructured": "Park JY, Park JM, Jang JS, Choi JE, Kim KM, Cha SI, Kim CH, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Lee JT, Jung TH: Caspase 9 promoter polymorphisms and risk of primary lung cancer. Hum Mol Genet. 2006, 15: 1963-1971. 10.1093/hmg/ddl119.",
      "volume": "15",
      "year": "2006"
    },
    {
      "DOI": "10.1073/pnas.0508390102",
      "author": "SL Harris",
      "doi-asserted-by": "publisher",
      "first-page": "16297",
      "journal-title": "Proc Nat Acad Sci U S A",
      "key": "11_CR17",
      "unstructured": "Harris SL, Gil G, Robins H, Hu W, Hirshfield K, Bond E, Bond G, Levine AJ: Detection of functional single-nucleotide polymorphisms that affect apoptosis. Proc Nat Acad Sci U S A. 2005, 102: 16297-16302. 10.1073/pnas.0508390102.",
      "volume": "102",
      "year": "2005"
    },
    {
      "DOI": "10.1023/B:CACO.0000036173.99930.75",
      "author": "SY Ho",
      "doi-asserted-by": "publisher",
      "first-page": "657",
      "journal-title": "Cancer Causes Control",
      "key": "11_CR18",
      "unstructured": "Ho SY, Wang YJ, Chen HL, Chen CH, Chang CJ, Wang PJ, Chen HH, Guo HR: Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the −308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control. 2004, 15: 657-663.",
      "volume": "15",
      "year": "2004"
    },
    {
      "DOI": "10.1093/carcin/bgl036",
      "author": "K Wagner",
      "doi-asserted-by": "publisher",
      "first-page": "1867",
      "journal-title": "Carcinogenesis",
      "key": "11_CR19",
      "unstructured": "Wagner K, Hemminki K, Grzybowska E, Klaes R, Burwinkel B, Bugert P, Schmutzler RK, Wappenschmidt B, Butkiewicz D, Pamula J, Pekala W, Försti A: Polymorphisms in genes involved in GH1 release and their association with breast cancer risk. Carcinogenesis. 2006, 27: 1867-1875. 10.1093/carcin/bgl036.",
      "volume": "27",
      "year": "2006"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-05-0039",
      "author": "X Ma",
      "doi-asserted-by": "publisher",
      "first-page": "8592",
      "journal-title": "Clin Cancer Res",
      "key": "11_CR20",
      "unstructured": "Ma X, Ruan G, Wang Y, Li Q, Zhu P, Qin YZ, Li JL, Liu YR, Ma D, Zhao H: Two single-nucleotide polymorphisms with linkage disequilibrium in the human programmed cell death 5 gene 5′regulatory region affect promoter activity and the susceptibility of chronic myelogenous leukemia in Chinese population. Clin Cancer Res. 2005, 11: 8592-8599. 10.1158/1078-0432.CCR-05-0039.",
      "volume": "11",
      "year": "2005"
    },
    {
      "DOI": "10.1136/mp.56.4.205",
      "author": "O Moshynska",
      "doi-asserted-by": "publisher",
      "first-page": "205",
      "journal-title": "Mol Pathol",
      "key": "11_CR21",
      "unstructured": "Moshynska O, Sankaran K, Saxena A: Molecular detection of the G(−248)A BAX promoter nucleotide change in B cell chronic lymphocytic leukaemia. Mol Pathol. 2003, 56: 205-209. 10.1136/mp.56.4.205.",
      "volume": "56",
      "year": "2003"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-05-0825",
      "author": "GL Bond",
      "doi-asserted-by": "publisher",
      "first-page": "5481",
      "journal-title": "Cancer Res",
      "key": "11_CR22",
      "unstructured": "Bond GL, Hu W, Levine A: A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect. Cancer Res. 2005, 65: 5481-5484. 10.1158/0008-5472.CAN-05-0825.",
      "volume": "65",
      "year": "2005"
    },
    {
      "DOI": "10.1093/nar/23.14.2584",
      "author": "A Zauberman",
      "doi-asserted-by": "publisher",
      "first-page": "2584",
      "journal-title": "Nucleic Acids Res",
      "key": "11_CR23",
      "unstructured": "Zauberman A, Flusberg D, Haupt Y, Barak Y, Oren M: A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res. 1995, 23: 2584-2592. 10.1093/nar/23.14.2584.",
      "volume": "23",
      "year": "1995"
    },
    {
      "DOI": "10.1016/S0092-8674(00)00123-9",
      "author": "S Ries",
      "doi-asserted-by": "publisher",
      "first-page": "321",
      "journal-title": "Cell",
      "key": "11_CR24",
      "unstructured": "Ries S, Biederer C, Woods D, Shifman O, Shirasawa S, Sasazuki T, McMahon M, Oren M, McCormick F: Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell. 2000, 103: 321-330. 10.1016/S0092-8674(00)00123-9.",
      "volume": "103",
      "year": "2000"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-06-0180",
      "author": "GL Bond",
      "doi-asserted-by": "publisher",
      "first-page": "5104",
      "journal-title": "Cancer Res",
      "key": "11_CR25",
      "unstructured": "Bond GL, Hirshfield KM, Kirchhoff T, Alexe G, Bond EE, Robins H, Bartel F, Taubert H, Wuerl P, Hait W, Toppmeyer D, Offit K, Levine AJ: MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner. Cancer Res. 2006, 66: 5104-5110. 10.1158/0008-5472.CAN-06-0180.",
      "volume": "66",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.cell.2004.11.022",
      "author": "GL Bond",
      "doi-asserted-by": "publisher",
      "first-page": "591",
      "journal-title": "Cell",
      "key": "11_CR26",
      "unstructured": "Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, Onel K, Yip L, Hwang SJ, Strong LC, Lozano G, Levine AJ: A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell. 2004, 119: 591-602. 10.1016/j.cell.2004.11.022.",
      "volume": "119",
      "year": "2004"
    },
    {
      "DOI": "10.1136/jmg.2006.043539",
      "author": "GL Bond",
      "doi-asserted-by": "publisher",
      "first-page": "950",
      "journal-title": "J Med Genet",
      "key": "11_CR27",
      "unstructured": "Bond GL, Menin C, Bertorelle R, Alhopuro P, Aaltonen LA, Levine AJ: MDM2 SNP309 accelerates colorectal tumour formation in women. J Med Genet. 2006, 43: 950-952. 10.1136/jmg.2006.043539.",
      "volume": "43",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.onc.1210199",
      "author": "GL Bond",
      "doi-asserted-by": "publisher",
      "first-page": "1317",
      "journal-title": "Oncogene",
      "key": "11_CR28",
      "unstructured": "Bond GL, Levine AJ: A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans. Oncogene. 2007, 26: 1317-1323. 10.1038/sj.onc.1210199.",
      "volume": "26",
      "year": "2007"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-06-0111",
      "author": "N Dharel",
      "doi-asserted-by": "publisher",
      "first-page": "4867",
      "journal-title": "Clin Cancer Res",
      "key": "11_CR29",
      "unstructured": "Dharel N, Kato N, Muroyama R, Moriyama M, Shao RX, Kawabe T, Omata M: MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C. Clin Cancer Res. 2006, 12: 4867-4871. 10.1158/1078-0432.CCR-06-0111.",
      "volume": "12",
      "year": "2006"
    },
    {
      "DOI": "10.1200/JCO.2005.04.1459",
      "author": "N Ohmiya",
      "doi-asserted-by": "publisher",
      "first-page": "4434",
      "journal-title": "J Clin Oncol",
      "key": "11_CR30",
      "unstructured": "Ohmiya N, Taguchi A, Mabuchi N, Itoh A, Hirooka Y, Niwa Y, Goto H: MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis. J Clin Oncol. 2006, 24: 4434-4440. 10.1200/JCO.2005.04.1459.",
      "volume": "24",
      "year": "2006"
    },
    {
      "DOI": "10.1111/j.1365-2133.2007.07994.x",
      "author": "S Wilkening",
      "doi-asserted-by": "publisher",
      "first-page": "375",
      "journal-title": "Br J Dermatol",
      "key": "11_CR31",
      "unstructured": "Wilkening S, Hemminki K, Rudnai P, Gurzau E, et al: No association between MDM2 SNP309 promoter polymorphism and basal cell carcinoma of the skin. Br J Dermatol. 2007, 157: 375-377. 10.1111/j.1365-2133.2007.07994.x.",
      "volume": "157",
      "year": "2007"
    },
    {
      "author": "A Petenkaya",
      "first-page": "4975",
      "journal-title": "Anticancer Res",
      "key": "11_CR32",
      "unstructured": "Petenkaya A, Bozkurt B, Akilli-Ozturk O, Kaya HS, Gur-Dedeoglu B, Yulug IG: Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk. Anticancer Res. 2006, 26: 4975-4977.",
      "volume": "26",
      "year": "2006"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-06-0217",
      "author": "SR Pine",
      "doi-asserted-by": "publisher",
      "first-page": "1559",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "11_CR33",
      "unstructured": "Pine SR, Mechanic LE, Bowman ED, Welsh JA, Chanock SC, Shields PG, Harris CC: MDM2 SNP309 and SNP354 are not associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2006, 15: 1559-1561. 10.1158/1055-9965.EPI-06-0217.",
      "volume": "15",
      "year": "2006"
    },
    {
      "DOI": "10.1093/nar/29.1.308",
      "author": "ST Sherry",
      "doi-asserted-by": "publisher",
      "first-page": "308",
      "journal-title": "Nucleic Acids Res",
      "key": "11_CR34",
      "unstructured": "Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K: dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001, 29: 308-311. 10.1093/nar/29.1.308.",
      "volume": "29",
      "year": "2001"
    },
    {
      "DOI": "10.1006/abio.1999.4293",
      "author": "D Labuda",
      "doi-asserted-by": "publisher",
      "first-page": "84",
      "journal-title": "Anal Biochem",
      "key": "11_CR35",
      "unstructured": "Labuda D, Krajinovic M, Richer C, Skoll A, Sinnett H, Yotova V, Sinnett D: Rapid detection of CYP1A1, CYP2D6, and NAT variants by multiplex polymerase chain reaction and allele-specific oligonucleotide assay. Anal Biochem. 1999, 275: 84-92. 10.1006/abio.1999.4293.",
      "volume": "275",
      "year": "1999"
    },
    {
      "DOI": "10.1086/319501",
      "author": "M Stephens",
      "doi-asserted-by": "publisher",
      "first-page": "978",
      "journal-title": "Am J Hum Genet",
      "key": "11_CR36",
      "unstructured": "Stephens M, Smith NJ, Donnelly P: A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001, 68: 978-989. 10.1086/319501.",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.1002/humu.20523",
      "author": "G Idelman",
      "doi-asserted-by": "publisher",
      "first-page": "824",
      "journal-title": "Hum Mutat",
      "key": "11_CR37",
      "unstructured": "Idelman G, Taylor JG, Tongbai R, Chen RA, Haggerty CM, Bilke S, Chanock SJ, Gardner K: Functional profiling of uncommon VCAM1 promoter polymorphisms prevalent in African American populations. Hum Mutat. 2007, 28: 824-829. 10.1002/humu.20523.",
      "volume": "28",
      "year": "2007"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-07-0634",
      "author": "Z Hu",
      "doi-asserted-by": "publisher",
      "first-page": "2717",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "11_CR38",
      "unstructured": "Hu Z, Jin G, Wang L, Chen F, Wang X, Shen H: MDM2 promoter polymorphism snp309 contributes to tumor susceptibility: evidence from 21 case–control studies. Cancer Epidemiol Biomarkers Prev. 2007, 16: 2717-2723. 10.1158/1055-9965.EPI-07-0634.",
      "volume": "16",
      "year": "2007"
    },
    {
      "author": "M Esteller",
      "first-page": "2816",
      "journal-title": "Cancer Res",
      "key": "11_CR39",
      "unstructured": "Esteller M, Cordon-Cardo C, Corn PG, Meltzer SJ, Pohar KS, Watkins DN, Capella G, Peinado MA, Matias-Guiu X, Prat J, Baylin SB, Herman JG: p14ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2. Cancer Res. 2001, 61: 2816-2821.",
      "volume": "61",
      "year": "2001"
    },
    {
      "DOI": "10.1016/S0959-437X(99)00038-6",
      "author": "CJ Sherr",
      "doi-asserted-by": "publisher",
      "first-page": "94",
      "journal-title": "Curr Opin Genet Dev",
      "key": "11_CR40",
      "unstructured": "Sherr CJ, Weber JD: The ARF/p53 pathway. Curr Opin Genet Dev. 2000, 10: 94-99. 10.1016/S0959-437X(99)00038-6.",
      "volume": "10",
      "year": "2000"
    },
    {
      "DOI": "10.1038/sj.onc.1202512",
      "author": "M Dobbelstein",
      "doi-asserted-by": "publisher",
      "first-page": "2101",
      "journal-title": "Oncogene",
      "key": "11_CR41",
      "unstructured": "Dobbelstein M, Wienzek S, Konig C, Roth J: Inactivation of the p53-homologue p73 by the mdm2-oncoprotein. Oncogene. 1999, 18: 2101-2106. 10.1038/sj.onc.1202512.",
      "volume": "18",
      "year": "1999"
    },
    {
      "DOI": "10.1038/375694a0",
      "author": "ZX Xiao",
      "doi-asserted-by": "publisher",
      "first-page": "694",
      "journal-title": "Nature",
      "key": "11_CR42",
      "unstructured": "Xiao ZX, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR, Livingston DM: Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature. 1995, 375: 694-698. 10.1038/375694a0.",
      "volume": "375",
      "year": "1995"
    },
    {
      "DOI": "10.1016/S0092-8674(00)81401-4",
      "author": "Y Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "725",
      "journal-title": "Cell",
      "key": "11_CR43",
      "unstructured": "Zhang Y, Xiong Y, Yarbrough WG: ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 1998, 92: 725-734. 10.1016/S0092-8674(00)81401-4.",
      "volume": "92",
      "year": "1998"
    },
    {
      "DOI": "10.2174/1568009053332618",
      "author": "Z Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "9",
      "journal-title": "Curr Cancer Drug Targets",
      "key": "11_CR44",
      "unstructured": "Zhang Z, Zhang R: p53-independent activities of MDM2 and their relevance to cancer therapy. Curr Cancer Drug Targets. 2005, 5: 9-20. 10.2174/1568009053332618.",
      "volume": "5",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.semcancer.2009.10.003",
      "author": "MP Dickens",
      "doi-asserted-by": "publisher",
      "first-page": "10",
      "journal-title": "Semin Cancer Biol",
      "key": "11_CR45",
      "unstructured": "Dickens MP, Fitzgerald R, Fischer PM: Small-molecule inhibitors of MDM2 as new anticancer therapeutics. Semin Cancer Biol. 2010, 20: 10-18. 10.1016/j.semcancer.2009.10.003.",
      "volume": "20",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nrc2763",
      "author": "CJ Brown",
      "doi-asserted-by": "publisher",
      "first-page": "862",
      "journal-title": "Nat Rev Cancer",
      "key": "11_CR46",
      "unstructured": "Brown CJ, Lain S, Verma CS, Fersht AR, Lane DP: Awakening guardian angels: drugging the p53 pathway. Nat Rev Cancer. 2009, 9: 862-873. 10.1038/nrc2763.",
      "volume": "9",
      "year": "2009"
    },
    {
      "DOI": "10.1101/gad.8.15.1739",
      "author": "Y Barak",
      "doi-asserted-by": "publisher",
      "first-page": "1739",
      "journal-title": "Genes Dev",
      "key": "11_CR47",
      "unstructured": "Barak Y, Gottlieb E, Juven-Gershon T, Oren M: Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential. Genes Dev. 1994, 8: 1739-1749. 10.1101/gad.8.15.1739.",
      "volume": "8",
      "year": "1994"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-07-5155",
      "author": "M Wang",
      "doi-asserted-by": "publisher",
      "first-page": "3633",
      "journal-title": "Clin Cancer Res",
      "key": "11_CR48",
      "unstructured": "Wang M, Zhang Z, Zhu H, Fu G, Wang S, Wu D, Zhou J, Wei Q, Zhang Z: A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population. Clin Cancer Res. 2008, 14: 3633-3640. 10.1158/1078-0432.CCR-07-5155.",
      "volume": "14",
      "year": "2008"
    },
    {
      "DOI": "10.1074/jbc.M505203200",
      "author": "NC Arva",
      "doi-asserted-by": "publisher",
      "first-page": "26776",
      "journal-title": "J Biol Chem",
      "key": "11_CR49",
      "unstructured": "Arva NC, Gopen TR, Talbott KE, Campbell LE, Chicas A, White DE, Bond GL, Levine AJ, Bargonetti J: A chromatin-associated and transcriptionally inactive p53-Mdm2 complex occurs in mdm2 SNP309 homozygous cells. J Biol Chem. 2005, 280: 26776-26787. 10.1074/jbc.M505203200.",
      "volume": "280",
      "year": "2005"
    },
    {
      "DOI": "10.1093/carcin/bgm191",
      "author": "S Wilkening",
      "doi-asserted-by": "publisher",
      "first-page": "2262",
      "journal-title": "Carcinogenesis",
      "key": "11_CR50",
      "unstructured": "Wilkening S, Bermejo JL, Hemminki K: MDM2 SNP309 and cancer risk: a combined analysis. Carcinogenesis. 2007, 28: 2262-2267. 10.1093/carcin/bgm191.",
      "volume": "28",
      "year": "2007"
    },
    {
      "DOI": "10.1186/1471-2407-11-208",
      "author": "Y Wan",
      "doi-asserted-by": "publisher",
      "first-page": "208",
      "journal-title": "BMC Cancer",
      "key": "11_CR51",
      "unstructured": "Wan Y, Wu W, Yin Z, Guan P, Zhou B: MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis. BMC Cancer. 2011, 11: 208-10.1186/1471-2407-11-208.",
      "volume": "11",
      "year": "2011"
    }
  ],
  "reference-count": 51,
  "references-count": 51,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/1479-7364-6-15"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Identification of functional DNA variants in the constitutive promoter region of MDM2"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "6"
}